Navigation Links
MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop
Date:3/17/2009

ANN ARBOR, Mich., March 17 /PRNewswire-USNewswire/ -- MichBio, the association for Michigan biosciences, will host Harry Stylli, Ph.D., president and CEO of San Diego, CA-based Sequenom, Inc. as the keynote speaker for its May 6 Annual Business Meeting at the Kensington Court Hotel in Ann Arbor. Sequenom has established a presence in Michigan with recent acquisitions of the Center for Molecular Medicine (CMM) in Grand Rapids and Ann Arbor-based Sensigen.

Dr. Harry Stylli has a track record of nearly two decades, demonstrating entrepreneurial leadership in the biotechnology and pharmaceutical industries, and has broad experience in successfully translating innovative technology into commercial opportunities. He was appointed president, CEO, and a board member of Sequenom, Inc. in 2005. Most recently, he served as president and CEO of Xencor, Inc., a privately held biotechnology company. Previously, Dr. Stylli was president and CEO of CovX Pharmaceuticals. Dr. Stylli co-founded Aurora Biosciences in 1995, and in 2001 he was key to the success of Aurora's acquisition by Vertex Pharmaceuticals. Following the merger, Dr. Stylli continued on with the company as president of Aurora Biosciences and Panvera. From 1987 to 1995, Dr. Stylli held various positions with GlaxoSmithKline. Dr. Stylli is a director of Molecular Insight Pharmaceuticals, Inc., and an advisor to Nanosyn. He has a B.S. degree from the University of East London, U.K., a Ph.D. from London University's Faculty of Medicine, and an M.B.A. from the U.K.'s Open University.

The MichBio Annual Business Meeting draws the industry's leaders and most influential bioscience professionals from across the state. It will be held at the Kensington Court Hotel in Ann Arbor, MI. Reception and networking begin at 5:00 p.m., followed by a dinner meeting at 6:30 p.m. and keynote address at 7:15 p.m. The cost before May 1 is $80 for members, $110 for non-members. After May 1
'/>"/>

SOURCE MichBio
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide
2. MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile
3. MichBio Expo Will Feature Sessions for Michigan Manufacturers Interested in Entering Medical Device Market
4. Presenters Announced For MichBio Expos Emerging Business Showcase
5. Early-Bird Pricing Ends Soon for MichBio Expo Attendees and Exhibitors; Award Nominations Due Nov. 1
6. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
7. Christine Poon Will Keynote MichBio Expo
8. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
9. MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop
10. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
11. MichBio Expo Opens in Lansing Next Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... PLEASANTON, Calif. , Dec. 19, 2014  Roche ... acquisition of Bina Technologies, Inc. (Bina), a privately ... California , USA. Bina provides a big ... next generation sequencing (NGS) data. Bina,s proprietary on-market ... translational and academic researchers to perform fast and ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources Group ... grow at a 12 percent compound annual growth rate ... the aging population and the increasing adoption of dental ... will also spur demand for dental biomaterials ... implant and periodontal treatments. Other key findings ...
(Date:12/19/2014)... 18, 2014 BioPlus Specialty ... specialty pharmacies, has an expanded team of Regional ... consultants for prescriber offices in their regions, with ... “We have a variety of Regional Pharmaceutical Care ... specializing in hepatitis C help prescribers understand all ...
(Date:12/19/2014)... LayerBio is an MIT spin-off developing ... The National Eye Institute (NEI) at the National Institutes ... SBIR grant to develop a drug-eluting intraocular lens (IOL) ... cause of vision loss in people over age 40 ... Dr. Ken Mandell, LayerBio’s Founder and CEO, "There is ...
Breaking Biology Technology:Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... call "hostile-environment technology." These are the machines, devices and ... are dangerous or impossible for humans to tread. Like ... reactor facilities. Two Arizona State University electrical engineers ... generation of these technologies, supported by a recent $1.7 ...
... BRNO, Czech Republic, November 16, 2011 ... provides complete diagnostics, treatment, and preventive care in ... MMCI is the only health care provider in ... the OECI (Organisation of European Cancer Institutes). ...
... Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company ... today announced top-line data from its recently completed ... pharmacodynamics (PD), safety and tolerability of subcutaneous bolus ... chronic heart failure. Nile is developing cenderitide as ...
Cached Biology Technology:Arizona State University engineers aim to improve performance of technology in extreme environments 2Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS 2Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS 3Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint 2Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint 3Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint 4
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
(Date:12/15/2014)... 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a ... recognition system measures the overall facial feature of ... and the distance between eyes. Facial recognition is ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... analysis has found that many doctors report that they ... and testing services to their female patients. Published early ... the American Cancer Society, the study indicates that efforts ... and discourage them for average-risk women. Women with ...
... association study published in the August issue of ... that can predict which patients with Hodgkin,s lymphoma are ... treatment. Knowing in advance who is at risk could ... patients who are most susceptible to long-term damage. ...
... target for nitric oxide has been revealed in studies of how ... cause of food-poisoning. "Nitric oxide is naturally produced ... body to ward off infection," explained the senior author of the ... professor of laboratory medicine, microbiology and medicine. Nitric oxide ...
Cached Biology News:Mismatch between cancer genetics counseling and testing guidelines and physician practices 22 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma 22 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma 3New target found for nitric oxide's attack on salmonella bacteria 2New target found for nitric oxide's attack on salmonella bacteria 3
... Chicken polyclonal to LYZL6 ( Abpromise ... Antigen: Synthetic peptide: ... HVDCQD , corresponding to amino acids ... Entrez Gene ID: 57151 ...
Rabbit polyclonal to UBC12 (rating: ****) ( Abpromise for all tested applications). Antigen: Synthetic peptide: RGGYIGSTYFER, corresponding to amino acids 169-180 of UBC12 Entrez Gene ID: 90...
Human acetylcholine receptor (AChR)-alpha. Exhibits homogenous, high affinity,binding to the receptor. Binds weakly to a64-78. Inhibits binding of many,myasthenia gravis sera to human AChR....
Mouse Anti-Lamin B...
Biology Products: